On the basis of system, the China cardiology information system market is segmented into integrated and standalone systems. In 2018, integrated systems accounted for the largest share of the China cardiology market. The large share of this segment can be attributed to the increasing adoption of these systems by healthcare providers and the increasing incidence & prevalence of cardiovascular diseases.
By component, the software segment accounted for the largest market share in 2018
On the basis of component, the China cardiology information system market is segmented into software, hardware, and service. The software segment accounted for the largest market share in 2018. This is attributed to the rising number of hospitals and the consequent increase in the demand for CVIS and CPACS, among other technologies.
L3A Hospitals are the largest end users in the China cardiology information system market
Based on end user, the China cardiology information system market is segmented into L3A, L3B, and L2 hospitals. The L3A hospitals segment accounted for the largest market share in 2018. The increasing number of L3A hospitals and the rising incidence of cardiovascular diseases in China are the major market drivers for this segment.
The key players in the China cardiology information system market are Philips Healthcare (Netherlands), CREALIFE Medical Technology (China), Central Data Network (Australia), Infinitt Healthcare (South Korea), and Esaote (Italy).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
